RAPT Therapeutics Inc.

NASDAQ: RAPT · Real-Time Price · USD
11.79
0.54 (4.80%)
At close: Aug 15, 2025, 3:59 PM
11.65
-1.18%
After-hours: Aug 15, 2025, 06:13 PM EDT

RAPT Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-106.49M -116.51M -129.87M -107.49M -120.43M -118.05M -116.8M -108.87M -98.74M -92.64M -83.84M -78.82M -76.23M -73.16M -69.2M -64.01M -59.99M -56.27M
Depreciation & Amortization
1.06M 1.14M 1.2M 1.24M 1.27M 1.23M 1.22M 1.15M 1.08M 1.08M 1.05M 1.03M 995K 977K 996K 1.03M 1.06M 1.2M
Stock-Based Compensation
18.34M 19.18M 19.93M 19.77M 19.54M 18.39M 17.09M 15.69M 14.22M 12.66M 11.26M 10.32M 9.75M 9.97M 9.95M 10.42M 10.14M 9.29M
Other Working Capital
35.1M 40K 34.37M -1.34M -2.22M -2.84M -1.84M -3.56M -3.36M -4.66M -5.04M -5.26M -4.95M -4.78M -5.23M -3.69M -4.77M 853K
Other Non-Cash Items
-38.46M -187K 6.28M 10.73M 11.28M 12.03M 4.82M 45K 108K 666K 2.09M 2.76M 2.7M 1.84M 1.53M -11.56M -11.99M -12.42M
Deferred Income Tax
n/a n/a n/a -5.15M -6.71M -8.87M -8.87M -3.73M -2.16M n/a n/a n/a n/a n/a n/a 12.72M 12.72M 12.72M
Change in Working Capital
33.8M -12.26M 25.91M -12.96M -3.07M -3.51M 5.5M 3.58M -1.92M 4.44M -1.33M -3.9M -1.19M -2.32M -4.3M -4.32M -5.09M -182K
Operating Cash Flow
-91.74M -108.63M -83.3M -100.61M -104.88M -105.53M -97.05M -92.14M -87.41M -73.8M -70.77M -68.6M -63.97M -62.69M -61.03M -55.71M -53.15M -45.66M
Capital Expenditures
-101K -60K -122K -188K -237K -471K -1.13M -1.11M -1.12M -1.46M -845K -1.19M -1.18M -677K -755K -535K -591K -527K
Cash Acquisitions
n/a n/a n/a -20.71M -46.52M -79.19M -105.26M -43.33M 2K 42.56M 68.63M 27.41M 9.89M n/a n/a 8M 8M 8M
Purchase of Investments
-186.86M -155.16M -82.22M -106.67M -121.55M -140.43M -161.5M -184.38M -192.57M -222.68M -190.86M -129.65M -118.51M -155.3M -164.98M -164.68M -146.15M -108.19M
Sales Maturities Of Investments
140.24M 134.98M 135.04M 181.05M 203.28M 235.62M 266.75M 227.71M 192.56M 180.12M 146.21M 110.72M 103M 86.05M 84.39M 115.25M 112.01M 80.67M
Other Investing Acitivies
n/a n/a 15.99M 36.7M 62.51M 95.18M 105.26M 43.33M -2K -42.56M -44.65M -18.92M -15.51M -69.24M -80.59M -73.09M -57.8M 13.82M
Investing Cash Flow
-46.72M -20.25M 52.7M 74.18M 81.49M 94.71M 104.13M 42.22M -1.12M -44.02M -45.49M -20.11M -16.69M -69.92M -81.35M -49.96M -34.73M -28.04M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
77K 778K 845K 1.23M 1.33M 1.4M 1.45M 1.32M 1.49M 1.38M 1.39M 1.47M 1.67M 2.03M 2.02M 2.09M 1.38M 1.22M
Financial Cash Flow
143.28M 143.82M 152.85M 10.2M 10.3M 10.37M 1.45M 76.35M 81.49M 131.16M 131.18M 56.42M 51.64M 140.31M 141.48M 145.44M 145.13M 6.89M
Net Cash Flow
4.81M 14.94M 122.26M -16.23M -13.09M -451K 8.53M 26.43M -7.04M 13.35M 14.92M -32.29M -29.02M 7.7M -891K 39.77M 57.26M -66.81M
Free Cash Flow
-91.84M -108.69M -83.42M -100.8M -105.11M -106M -98.17M -93.25M -88.53M -75.25M -71.62M -69.79M -65.15M -63.37M -61.78M -56.25M -53.74M -46.18M